Diagnosis and management of osteoporosis in the older senior

References

• KanisJADiagnosis of osteoporosis and assessment of fracture riskLancet200235993211929193612057569
   PubMed Web of Science ®Google Scholar
• National Health and Nutrition Examination Survey Osteoporosis Data Brief 12/02 Osteoporosis Department of Health and Human Services. Centers for Disease Control and Prevention. National Center for Health Statistics. [Cited 2009 Jan 9.] Available from: http://www.cdc.gov/nchs/data/nhanes/databriefs/osteoporosis.pdf
   Google Scholar
• LookerACJohnstonCCJrWahnerHWPrevalence of low femoral bone density in older US women from NHANES IIIJ Bone Miner Res19951057968027639115
   PubMed Web of Science ®Google Scholar
• HeWSenguptaManishaVelkoffVicotoria ADeBarrowsKimberly AUS Census Bureau, Current Population Reports, P-23–209, 65+ in the United States: 2005, US Government Printing Office Washington, DC2005
   Google Scholar
• Clinician’s Guide to Prevention and Treatment of Osteoporosis Washington DC: National Osteoporosis Foundation; c2008 [updated 2008 Feb 21; cited 2009 Jan 9]. Available from: http://www.nof.org/professionals/NOF_Clinicians_Guide.pdf
   Google Scholar
• Facts and statistics about osteoporosis and its impact. International Osteoporosis Foundation; c 1999–2007; cited 2009 Jan 9. Available from: http://www.iofbonehealth.org/facts-and-statistics.html
   Google Scholar
• CooperCAtkinsonEJO'FallonWMMeltonLJ3rdIncidence of clinically diagnosed vertebral fractures: a population-based study in Rochester, Minnesota, 1985–1989J Bone Miner Res1992722212271570766
   PubMed Web of Science ®Google Scholar
• CummingsSRNevittMCBrownerWSRisk factors for hip fracture in white women. Study of Osteoporotic Fractures Research GroupN Engl J Med1995332127677737862179
   PubMed Web of Science ®Google Scholar
• JacobsenSJGoldbergJMilesTPBrodyJAStiersWRimmAAHip fracture incidence among the old and very old: a population-based study of 745,435 casesAm J Public Health19908078718732356916
   PubMed Web of Science ®Google Scholar
• KozakLJDeFrancesCJHallMJNational hospital discharge survey: 2004 annual summary with detailed diagnosis and procedure dataVital Health Stat1320061621209
   Google Scholar
• WolinskyFDFitzgeraldJFStumpTEThe effect of hip fracture on mortality, hospitalization, and functional status: a prospective studyAm J Public Health19978733984039096540
   PubMed Web of Science ®Google Scholar
• LeibsonCLTostesonANGabrielSERansomJEMeltonLJMortality, disability, and nursing home use for persons with and without hip fracture: a population-based studyJ Am Geriatr Soc200250101644165012366617
   PubMed Web of Science ®Google Scholar
• GreendaleGABarrett-ConnorEInglesSHaileRLate physical and functional effects of osteoporotic fracture in women: the Rancho Bernardo StudyJ Am Geriatr Soc19954399559617657934
   PubMed Web of Science ®Google Scholar
• KadoDMBrownerWSPalermoLNevittMCGenantHKCummingsSRVertebral fractures and mortality in older women: a prospective study. Study of Osteoporotic Fractures Research GroupArch Intern Med1999159111215122010371229
   PubMed Web of Science ®Google Scholar
• JohnellOKanisJAOdenAMortality after osteoporotic fracturesOsteoporos Int2004151384214593451
   PubMed Web of Science ®Google Scholar
• MagazinerJLydickEHawkesWExcess mortality attributable to hip fracture in white women aged 70 years and olderAm J Public Health19978710163016369357344
   PubMed Web of Science ®Google Scholar
• TrombettiAHerrmannFHoffmeyerPSchurchMABonjourJPRizzoliRSurvival and potential years of life lost after hip fracture in men and age-matched womenOsteoporos Int200213973173712195537
   PubMed Web of Science ®Google Scholar
• FreedmanKBKaplanFSBilkerWBStromBLLoweRATreatment of osteoporosis: are physicians missing an opportunity?J Bone Joint Surg Am200082-A81063107010954094
   PubMed Web of Science ®Google Scholar
• ParikhSMogunHAvornJSolomonDHOsteoporosis medication use in nursing home patients with fractures in 1 US stateArch Intern Med2008168101111111518504340
   PubMedGoogle Scholar
• PerreaultSDragomirADesgagneATrends and determinants of antiresorptive drug use for osteoporosis among elderly womenPharmacoepidemiol Drug Saf2005141068569515645517
   PubMed Web of Science ®Google Scholar
• NeunerJMZimmerJKHamelMBDiagnosis and treatment of osteoporosis in patients with vertebral compression fracturesJ Am Geriatr Soc200351448349112657067
   PubMed Web of Science ®Google Scholar
• JachnaCMShiremanTIWhittleJEllerbeckEFRiglerSKDiffering patterns of antiresorptive pharmacotherapy in nursing facility residents and community dwellersJ Am Geriatr Soc20055381275128116078951
   PubMed Web of Science ®Google Scholar
• Colon-EmericCLylesKWLevineDAPrevalence and predictors of osteoporosis treatment in nursing home residents with known osteoporosis or recent fractureOsteoporos Int200718455355917120179
   PubMed Web of Science ®Google Scholar
• WrightRMUse of osteoporosis medications in older nursing facility residentsJ Am Med Dir Assoc20078745345717845948
   PubMed Web of Science ®Google Scholar
• BouxseinMLDeterminants of skeletal fragilityBest Pract Res Clin Rheumatol200519689791116301186
   PubMed Web of Science ®Google Scholar
• CloseJCLordSLMenzHBSherringtonCWhat is the role of falls?Best Pract Res Clin Rheumatol200519691393516301187
   PubMed Web of Science ®Google Scholar
• SchwartzAVNevittMCBrownBWJrKelseyJLIncreased falling as a risk factor for fracture among older women: the study of osteoporotic fracturesAm J Epidemiol2005161218018515632268
   PubMed Web of Science ®Google Scholar
• SambrookPNCameronIDChenJSInfluence of fall related factors and bone strength on fracture risk in the frail elderlyOsteoporos Int200718560361017216131
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention, National Center for Injury Prevention and Control. Web-based Injury Statistics Query and Reporting System (WISQARS) [online]. 2006[updated 2008 Nov 18; cited 2009 Jan 9] Available from: www.cdc.gov/ncipc/wisqars
   Google Scholar
• GrissoJAKelseyJLStromBLRisk factors for falls as a cause of hip fracture in women. The Northeast Hip Fracture Study GroupN Engl J Med199132419132613312017229
   PubMed Web of Science ®Google Scholar
• SpectorWShafferTPotterDECorrea-de-AraujoRRhona LimcangcoMRisk factors associated with the occurrence of fractures in US nursing homes: resident and facility characteristics and prescription medicationsJ Am Geriatr Soc200755332733317341233
   PubMed Web of Science ®Google Scholar
• CummingRGEpidemiology of medication-related falls and fractures in the elderlyDrugs Aging199812143539467686
   PubMed Web of Science ®Google Scholar
• WeiTSHuCHWangSHHwangKLFall characteristics, functional mobility and bone mineral density as risk factors of hip fracture in the community-dwelling ambulatory elderlyOsteoporos Int200112121050105511846332
   PubMed Web of Science ®Google Scholar
• NevittMCCummingsSRType of fall and risk of hip and wrist fractures: the study of osteoporotic fractures. The Study of Osteoporotic Fractures Research GroupJ Am Geriatr Soc19934111122612348227898
   PubMed Web of Science ®Google Scholar
• HolickMFVitamin D deficiencyN Engl J Med2007357326628117634462
   PubMed Web of Science ®Google Scholar
• HamidZRiggsASpencerTRedmanCBodennerDVitamin D deficiency in residents of academic long-term care facilities despite having been prescribed vitamin DJ Am Med Dir Assoc200782717517289534
   PubMed Web of Science ®Google Scholar
• LinneburSAVondracekSFVande GriendJPRuscinJMMcDermottMTPrevalence of vitamin D insufficiency in elderly ambulatory outpatients in Denver, ColoradoAm J Geriatr Pharmacother2007511817608242
   PubMedGoogle Scholar
• LipsPVitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implicationsEndocr Rev200122447750111493580
   PubMed Web of Science ®Google Scholar
• SahotaOMasudTSanPHoskingDJVitamin D insufficiency increases bone turnover markers and enhances bone loss at the hip in patients with established vertebral osteoporosisClin Endocrinol (Oxf)199951221722110468993
   PubMed Web of Science ®Google Scholar
• JanssenHCJPSamsonMMVerhaarHJJVitamin D deficiency, muscle function, and falls in elderly peopleAm J Clin Nutr200275461161511916748
   PubMed Web of Science ®Google Scholar
• SteinMSWarkJDSchererSCFalls relate to vitamin D and parathyroid hormone in an Australian nursing home and hostelJ Am Geriatr Soc199947101195120110522952
   PubMed Web of Science ®Google Scholar
• US Department of Health and Human ServicesBone health and osteoporosis: a report of the Surgeon GeneralRockville, MDUS Department of Health and Human Services, Office of the Surgeon General20041436
   Google Scholar
• SchousboeJTEnsrudKENymanJAMeltonLJ3rdKaneRLUniversal bone densitometry screening combined with alendronate therapy for those diagnosed with osteoporosis is highly cost-effective for elderly womenJ Am Geriatr Soc200553101697170416181168
   PubMed Web of Science ®Google Scholar
• SchousboeJTTaylorBCFinkHACost-effectiveness of bone densitometry followed by treatment of osteoporosis in older menJAMA2007298662963717684185
   PubMed Web of Science ®Google Scholar
• NelsonHDHelfandMWoolfSHAllanJDScreening for postmenopausal osteoporosis: a review of the evidence for the US Preventive Services Task ForceAnn Intern Med2002137652954112230356
   PubMed Web of Science ®Google Scholar
• KanisJABurletNCooperCEuropean guidance for the diagnosis and management of osteoporosis in postmenopausal womenOsteoporos Int200819439942818266020
   PubMed Web of Science ®Google Scholar
• BaimSBinkleyNBilezikianJPOfficial Positions of the International Society for Clinical Densitometry and executive summary of the 2007 ISCD Position Development ConferenceJ Clin Densitom2008111759118442754
   PubMed Web of Science ®Google Scholar
• NeunerJMBinkleyNSparapaniRALaudPWNattingerABBone density testing in older women and its association with patient ageJ Am Geriatr Soc200654348548916551317
   PubMed Web of Science ®Google Scholar
• KingABSaagKGBurgeRTPisuMGoelNFracture Reduction Affects Medicare Economics (FRAME): impact of increased osteoporosis diagnosis and treatmentOsteoporos Int200516121545155715942702
   PubMed Web of Science ®Google Scholar
• CurtisJRCarboneLChengHLongitudinal trends in use of bone mass measurement among older americans, 1999–2005J Bone Miner Res20082371061106718302495
   PubMed Web of Science ®Google Scholar
• McNallyDNKennyAMSmithJAAdherence of academic geriatric practitioners to osteoporosis screening guidelinesOsteoporos Int200718217718317043904
   PubMed Web of Science ®Google Scholar
• JubyAGThe use of calcaneal ultrasound evaluation of bone mineral density in cognitively impaired seniorsJ Am Med Dir Assoc20045637738115530175
   PubMedGoogle Scholar
• KriegMABarkmannRGonnelliSQuantitative ultrasound in the management of osteoporosis: the 2007 ISCD Official PositionsJ Clin Densitom20081116318718442758
   PubMed Web of Science ®Google Scholar
• ElliottMEDrinkaPJKrausePBinkleyNCMahoneyJEOsteoporosis assessment strategies for male nursing home residentsMaturitas200448322523315207888
   PubMed Web of Science ®Google Scholar
• ElliottMEBinkleyNCCarnesMFracture risks for women in long-term care: high prevalence of calcaneal osteoporosis and hypovitaminosis DPharmacotherapy200323670271012820811
   PubMed Web of Science ®Google Scholar
• FRAX WHO Fracture Risk Assessment Tool University of Sheffield UK: World Health Organization Collaborating Centre for Metabolic Bone Diseases.; c2008 [cited 2009 Jan 9]. Available from: http://www.shef.ac.uk/FRAX/
   Google Scholar
• EnsrudKEBlackDMPalermoLTreatment with alendronate prevents fractures in women at highest risk: results from the Fracture Intervention TrialArch Intern Med199715722261726249531231
   PubMed Web of Science ®Google Scholar
• Guideline for the prevention of falls in older personsAmerican Geriatrics Society, British Geriatrics Society, and American Academy of Orthopaedic Surgeons Panel on Falls PreventionJ Am Geriatr Soc200149566467211380764
   PubMed Web of Science ®Google Scholar
• ChangJTGanzDAQuality indicators for falls and mobility problems in vulnerable eldersJ Am Geriatr Soc200755Suppl 2S327S33417910554
   PubMed Web of Science ®Google Scholar
• MoylanKCBinderEFFalls in older adults: risk assessment, management and preventionAm J Med20071206493 e1e617524747
   PubMed Web of Science ®Google Scholar
• SinakiMNonpharmacologic interventions. Exercise, fall prevention, and role of physical medicineClin Geriatr Med200319233735912916290
   PubMed Web of Science ®Google Scholar
• BonaiutiDSBIovineRNegriniSRobinsonVKemperHCWellsGTugwellPCranneyAExercise for preventing and treating osteoporosis in postemenopausal womenCochrane Database of Systematic Reviews20022
   Web of Science ®Google Scholar
• NelsonMERejeskiWJBlairSNPhysical activity and public health in older adults: recommendation from the American College of Sports Medicine and the American Heart AssociationMed Sci Sports Exerc20073981435144517762378
   PubMed Web of Science ®Google Scholar
• Bischoff-FerrariHADawson-HughesBWillettWCEffect of Vitamin D on falls: a meta-analysisJAMA2004291161999200615113819
   PubMed Web of Science ®Google Scholar
• FosnightSMZafirauWJHazelettSEVitamin D supplementation to prevent falls In the elderly: evidence and practical considerationsPharmacotherapy200828222523418225968
   PubMed Web of Science ®Google Scholar
• FlickerLMacInnisRJSteinMSShould older people in residential care receive vitamin D to prevent falls? Results of a randomized trialJ Am Geriatr Soc200553111881188816274368
   PubMed Web of Science ®Google Scholar
• OnckenCPrestwoodKKleppingerAWangYCooneyJRaiszLImpact of smoking cessation on bone mineral density in postmenopausal womenJ Womens Health2006151011411150
   Web of Science ®Google Scholar
• CornuzJFeskanichDWillettWCColditzGASmoking, smoking cessation, and risk of hip fracture in womenAm J Med1999106331131410190380
   PubMed Web of Science ®Google Scholar
• SawkaAMBoulosPBeattieKDo hip protectors decrease the risk of hip fracture in institutional and community-dwelling elderly? A systematic review and meta-analysis of randomized controlled trialsOsteoporos Int200516121461147415990949
   PubMed Web of Science ®Google Scholar
• KielDPMagazinerJZimmermanSEfficacy of a hip protector to prevent hip fracture in nursing home residents: the HIP PRO randomized controlled trialJAMA2007298441342217652295
   PubMed Web of Science ®Google Scholar
• O’ConnellMBMaddenDMMurrayAMHeaneyRPKerznerLJEffects of proton pump inhibitors on calcium carbonate absorption in women: a randomized crossover trialAm J Med2005118777878115989913
   PubMed Web of Science ®Google Scholar
• YangYXLewisJDEpsteinSMetzDCLong-term proton pump inhibitor therapy and risk of hip fractureJAMA2006296242947295317190895
   PubMed Web of Science ®Google Scholar
• TangBMPEslickGDNowsonCSmithCBensoussanAUse of calcium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50 years and older: a meta-analysisLancet2007370958865766617720017
   PubMed Web of Science ®Google Scholar
• Bischoff-FerrariHAWillettWCWongJBGiovannucciEDietrichTDawson-HughesBFracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled trialsJAMA2005293182257226415886381
   PubMed Web of Science ®Google Scholar
• AvenellAGWGillespieLDO’ConnellDLVitamin D and vitamin D analogues for preventing fractures associated with involutional and post-menopausal osteoporosisCochrane Database of Systematic Reviews20053
   Web of Science ®Google Scholar
• BoonenSLipsPBouillonRBischoff-FerrariHAVanderschuerenDHaentjensPNeed for additional calcium to reduce the risk of hip fracture with vitamin d supplementation: evidence from a comparative metaanalysis of randomized controlled trialsJ Clin Endocrinol Metab20079241415142317264183
   PubMed Web of Science ®Google Scholar
• BroeKEChenTCWeinbergJBischoff-FerrariHAHolickMFKielDPA higher dose of vitamin d reduces the risk of falls in nursing home residents: a randomized, multiple-dose studyJ Am Geriatr Soc200755223423917302660
   PubMed Web of Science ®Google Scholar
• LawMWithersHMorrisJAndersonFVitamin D supplementation and the prevention of fractures and falls: results of a randomised trial in elderly people in residential accommodationAge Ageing200635548248616641143
   PubMed Web of Science ®Google Scholar
• LyonsRAJohansenABrophySPreventing fractures among older people living in institutional care: a pragmatic randomised double blind placebo controlled trial of vitamin D supplementationOsteoporos Int200718681181817473911
   PubMed Web of Science ®Google Scholar
• National Osteoporosis Guideline Group. World Health Organization Collaborating Centre for Metabolic Bone Diseases, University of Sheffield, UK. Guideline for the diagnosis and management of osteoporosis in postmenopausal women and men from the age of 50 years in the UK; 2008. [cited 2009 Jan 9]; Available from: http://www.shef.ac.uk/NOGG/
   Google Scholar
• BlackDMCummingsSRKarpfDBRandomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research GroupLancet19963489041153515418950879
   PubMed Web of Science ®Google Scholar
• US Food and Drug Administration. Center for Drug Evaluation and Research. FDA Alert: Information on Bisphosphonates[created: 2008 Jan 7, updated 2008 Nov 12; cited 2009, Jan]. Available from: http://www.fda.gov/cder/drug/infopage/bisphosphonates/default.htm
   Google Scholar
• WooSBHellsteinJWKalmarJRNarrative review: bisphosphonates and osteonecrosis of the jawsAnn Intern Med20061441075376116702591
   PubMed Web of Science ®Google Scholar
• KruegerCDWestPMSargentMLodolceAEPickardASBisphosphonate-induced osteonecrosis of the jawAnn Pharmacother200741227628417299010
   PubMed Web of Science ®Google Scholar
• US Food and Drug Administration. Center for Drug Evaluation and Research. Update of Safety Review Follow-up to the October 1, 2007 Early Communication about the Ongoing Safety Review of Bisphosphonates [created: 2008 Nov 12; cited 2009, Jan]. Available from: http://www.fda.gov/cder/drug/early_comm/bisphosphonates_update_200811.htm
   Google Scholar
• PapapoulosSEQuandtSALibermanUAHochbergMCThompsonDEMeta-analysis of the efficacy of alendronate for the prevention of hip fractures in postmenopausal womenOsteoporos Int200516546847415448985
   PubMed Web of Science ®Google Scholar
• ReginsterJMinneHWSorensenOHRandomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Vertebral Efficacy with Risedronate Therapy (VERT) Study GroupOsteoporos Int2000111839110663363
   PubMed Web of Science ®Google Scholar
• McClungMRGeusensPMillerPDEffect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study GroupN Engl J Med2001344533334011172164
   PubMed Web of Science ®Google Scholar
• HarrisSTWattsNBGenantHKEffects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study GroupJAMA1999282141344135210527181
   PubMed Web of Science ®Google Scholar
• ChesnutICSkagAChristiansenCEffects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosisJ Bone Miner Res20041981241124915231010
   PubMed Web of Science ®Google Scholar
• DelmasPDAdamiSStrugalaCIntravenous ibandronate injections in postmenopausal women with osteoporosis: one-year results from the dosing intravenous administration studyArthritis Rheum20065461838184616729277
   PubMed Web of Science ®Google Scholar
• LylesKWColon-EmericCSMagazinerJSZoledronic acid and clinical fractures and mortality after hip fractureN Engl J Med2007357181799180917878149
   PubMed Web of Science ®Google Scholar
• BlackDMDelmasPDEastellROnce-yearly zoledronic acid for treatment of postmenopausal osteoporosisN Engl J Med2007356181809182217476007
   PubMed Web of Science ®Google Scholar
• EttingerBBlackDMMitlakBHReduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) InvestigatorsJAMA1999282763764510517716
   PubMed Web of Science ®Google Scholar
• Barrett-ConnorEMoscaLCollinsPEffects of raloxifene on cardiovascular events and breast cancer in postmenopausal womenN Engl J Med2006355212513716837676
   PubMed Web of Science ®Google Scholar
• WooltortonEOsteoporosis treatment: raloxifene (Evista) and stroke mortalityCMAJ2006175214716804122
   PubMed Web of Science ®Google Scholar
• ChesnutCH3rdSilvermanSAndrianoKA randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the prevent recurrence of osteoporotic fractures study. PROOF Study GroupAm J Med2000109426727610996576
   PubMed Web of Science ®Google Scholar
• KnoppJADinerBMBlitzMLyritisGPRoweBHCalcitonin for treating acute pain of osteoporotic vertebral compression fractures: a systematic review of randomized, controlled trialsOsteoporos Int200516101281129015614441
   PubMed Web of Science ®Google Scholar
• NeerRMArnaudCDZanchettaJREffect of parathyroid hormone (1–34) on fractures and bone mineral density in postmenopausal women with osteoporosisN Engl J Med2001344191434144111346808
   PubMed Web of Science ®Google Scholar
• GreenspanSLBoneHGEttingerMPEffect of recombinant human parathyroid hormone (1–84) on vertebral fracture and bone mineral density in postmenopausal women with osteoporosis: a randomized trialAnn Intern Med2007146532633917339618
   PubMed Web of Science ®Google Scholar
• MeunierPJRouxCSeemanEThe effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosisN Engl J Med2004350545946814749454
   PubMed Web of Science ®Google Scholar
• ReginsterJYSeemanEDe VernejoulMCStrontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) studyJ Clin Endocrinol Metab20059052816282215728210
   PubMed Web of Science ®Google Scholar
• O’DonnellSCranneyAWellsGAAdachiJDReginsterJYStrontium ranelate for preventing and treating postmenopausal osteoporosisCochrane Database Syst Rev20064CD005326
   Web of Science ®Google Scholar
• AndersonGLLimacherMAssafAREffects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women’s Health Initiative randomized controlled trialJAMA2004291141701171215082697
   PubMed Web of Science ®Google Scholar
• CauleyJARobbinsJChenZEffects of estrogen plus progestin on risk of fracture and bone mineral density: the Women’s Health Initiative randomized trialJAMA2003290131729173814519707
   PubMed Web of Science ®Google Scholar
• AriasE National Vitals Statistic Report: United States Life Tables, 2003 Department of Health and Human Services Centers for Disease Control and Prevention. National Center for Health Statistics. [created 2006 April 16, updated 2007 March 28; cited 2009 Jan 9] Available from: http://www.cdc.gov/nchs/data/statab/lewk3_2003.pdf.
   Google Scholar
• MaricicMAdachiJDSarkarSWuWWongMHarperKDEarly effects of raloxifene on clinical vertebral fractures at 12 months in postmenopausal women with osteoporosisArch Intern Med2002162101140114312020184
   PubMed Web of Science ®Google Scholar
• RouxCSeemanEEastellREfficacy of risedronate on clinical vertebral fractures within six monthsCurr Med Res Opin200420443343915119979
   PubMed Web of Science ®Google Scholar
• HochbergMCThompsonDEBlackDMEffect of alendronate on the age-specific incidence of symptomatic osteoporotic fracturesJ Bone Miner Res200520697197615883637
   PubMed Web of Science ®Google Scholar
• BoonenSMcClungMREastellREl-Hajj FuleihanGBartonIPDelmasPSafety and efficacy of risedronate in reducing fracture risk in osteoporotic women aged 80 and older: implications for the use of antiresorptive agents in the old and oldest oldJ Am Geriatr Soc200452111832183915507059
   PubMed Web of Science ®Google Scholar
• CauleyJABlackDBoonenSREffect of Zoledronic acid (ZOL) 5 mg on fracture risk by age and geographic region in women with postmenopausal osteoporosis: results from HORIZON-PFTOsteoporos Int200718Suppl 2S232Abstract from the Seventh International Symposium on Osteoporosis: Translating Research into Clinical Practice#P8.32.
   Google Scholar
• BoonenSMarinFMellstromDSafety and efficacy of teriparatide in elderly women with established osteoporosis: bone anabolic therapy from a geriatric perspectiveJ Am Geriatr Soc200654578278916696744
   PubMed Web of Science ®Google Scholar
• MarcusRWangOSatterwhiteJMitlakBThe skeletal response to teriparatide is largely independent of age, initial bone mineral density, and prevalent vertebral fractures in postmenopausal women with osteoporosisJ Bone Miner Res2003181182312510801
   PubMed Web of Science ®Google Scholar
• SeemanEVellasBBenhamouCStrontium ranelate reduces the risk of vertebral and nonvertebral fractures in women eighty years of age and olderJ Bone Miner Res20062171113112016813532
   PubMed Web of Science ®Google Scholar
• GreenspanSLSchneiderDLMcClungMRAlendronate improves bone mineral density in elderly women with osteoporosis residing in long-term care facilities. A randomized, double-blind, placebo-controlled trialAnnals of Intern Med200213610742746
   Web of Science ®Google Scholar
• PunKKChanLWAnalgesic effect of intranasal salmon calcitonin in the treatment of osteoporotic vertebral fracturesClin Ther19891122052092660996
   PubMed Web of Science ®Google Scholar
• LyritisGPPaspatiIKarachaliosTIoakimidisDSkarantavosGLyritisPGPain relief from nasal salmon calcitonin in osteoporotic vertebral crush fractures. A double blind, placebo-controlled clinical studyActa Orthop Scand Suppl19972751121149385283
   PubMedGoogle Scholar
• OrwollESScheeleWHPaulSThe effect of teriparatide [human parathyroid hormone (1–34)] therapy on bone density in men with osteoporosisJ Bone Miner Res200318191712510800
   PubMed Web of Science ®Google Scholar
• SatoYIwamotoJKanokoTSatohKRisedronate sodium therapy for prevention of hip fracture in men 65 years or older after strokeArch Intern Med2005165151743174816087822
   PubMed Web of Science ®Google Scholar
• SatoYHondaYIwamotoJRisedronate and ergocalciferol prevent hip fracture in elderly men with Parkinson diseaseNeurology2007681291191517372126
   PubMed Web of Science ®Google Scholar
• RingeJDFaberHFarahmandPDorstAEfficacy of risedronate in men with primary and secondary osteoporosis: results of a 1-year studyRheumatol Int200626542743116001181
   PubMed Web of Science ®Google Scholar
• FinkelsteinJSHayesAHunzelmanJLWylandJJLeeHNeerRMThe effects of parathyroid hormone, alendronate, or both in men with osteoporosisN Engl J Med2003349131216122614500805
   PubMed Web of Science ®Google Scholar
• OrwollEEttingerMWeissSAlendronate for the treatment of osteoporosis in menN Engl J Med2000343960461010979796
   PubMed Web of Science ®Google Scholar
• EttingerMPFelsenbergDHarrisSTSafety and tolerability of oral daily and intermittent ibandronate are not influenced by ageJ Rheumatol200532101968197416206354
   PubMed Web of Science ®Google Scholar
• WeyckerDMacariosDEdelsbergJOsterGCompliance with osteoporosis drug therapy and risk of fractureOsteoporos Int200718327127717021945
   PubMed Web of Science ®Google Scholar
• BlouinJDragomirAMorideYSte-MarieLGFernandesJCPerreaultSImpact of noncompliance with alendronate and risedronate on the incidence of nonvertebral osteoporotic fractures in elderly womenBr J Clin Pharmacol200866111712718460036
   PubMed Web of Science ®Google Scholar
• SirisESHarrisSTRosenCJAdherence to bisphosphonate therapy and fracture rates in osteoporotic women: relationship to vertebral and nonvertebral fractures from 2 US claims databasesMayo Clin Proc20068181013102216901023
   PubMed Web of Science ®Google Scholar
• SorensenHTChristensenSMehnertFUse of bisphosphonates among women and risk of atrial fibrillation and flutter: population based case-control studyBMJ2008336764881381618334527
   PubMed Web of Science ®Google Scholar
• CummingsSRSchwartzAVBlackDMAlendronate and atrial fibrillationN Engl J Med2007356181895189617476024
   PubMed Web of Science ®Google Scholar
• HeckbertSRLiGCummingsSRSmithNLPsatyBMUse of alendronate and risk of incident atrial fibrillation in womenArch Intern Med2008168882683118443257
   PubMedGoogle Scholar
• VogelVGCostantinoJPWickerhamDLEffects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trialJAMA2006295232727274116754727
   PubMed Web of Science ®Google Scholar
• ClaseCMGargAXKiberdBAPrevalence of low glomerular filtration rate in nondiabetic Americans: Third National Health and Nutrition Examination Survey (NHANES III)J Am Soc Nephrol20021351338134911961022
   PubMed Web of Science ®Google Scholar
• JassalSKvon MuhlenDBarrett-ConnorEMeasures of renal function, BMD, bone loss, and osteoporotic fracture in older adults: the Rancho Bernardo studyJ Bone Miner Res200722220321017059370
   PubMed Web of Science ®Google Scholar
• MillerPDRouxCBoonenSBartonIPDunlapLEBurgioDESafety and efficacy of risedronate in patients with age-related reduced renal function as estimated by the Cockcroft and Gault method: a pooled analysis of nine clinical trialsJ Bone Miner Res200520122105211516294264
   PubMed Web of Science ®Google Scholar
• MillerPDSchwartzENChenPMisurskiDAKregeJHTeriparatide in postmenopausal women with osteoporosis and mild or moderate renal impairmentOsteoporos Int2007181596817013567
   PubMed Web of Science ®Google Scholar
• JamalSABauerDCEnsrudKEAlendronate treatment in women with normal to severely impaired renal function: an analysis of the fracture intervention trialJ Bone Miner Res200722450350817243862
   PubMed Web of Science ®Google Scholar
• IshaniABlackwellTJamalSACummingsSREnsrudKEThe effect of raloxifene treatment in postmenopausal women with CKDJ Am Soc Nephrol20081971430143818400939
   PubMed Web of Science ®Google Scholar